Upgrade to SI Premium - Free Trial

Allarity Therapeutics (ALLR) Misses Q3 EPS by 19c

November 14, 2025 4:23 PM

Allarity Therapeutics (NASDAQ: ALLR) reported Q3 EPS of ($0.19).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

Categories

Earnings